Tempus AI, Inc. key statistics and ratios
In fiscal 2025, Tempus AI, Inc. had return on equity of -89.5%, an operating margin of -19.9%, debt equal to 42.5% of equity and a current ratio of 3.13. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|
| Operating margin | −82.8% | −36.9% | −99.7% | −19.9% | −18.5% |
| Net margin | −90.4% | −40.3% | −101.8% | −19.3% | −12.5% |
| Free-cash-flow margin | −58.2% | −46.8% | −30.5% | −18.8% | −9.1% |
| Return on equity | — | — | — | −89.5% | −38.2% |
| Return on assets | — | −38.0% | −94.7% | −15.3% | −8.0% |
| Asset turnover | — | 0.94 | 0.93 | 0.79 | 0.64 |
| Current ratio | — | 1.51 | 2.29 | 3.13 | 2.61 |
| Debt to equity | — | — | 298.5% | 42.5% | 35.2% |
| Interest cover (operating income ÷ interest) | n/m | n/m | n/m | n/m | n/m |
| R&D as % of revenue | 25.9% | 17.0% | 21.5% | 13.6% | 13.1% |
| SG&A as % of revenue | 72.8% | 55.8% | 108.9% | 57.5% | 58.2% |
| Capital spending as % of revenue | 5.7% | 6.5% | 3.2% | 1.7% | 1.9% |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating margin | −25.3% | −26.9% | −19.6% | −18.3% | −16.7% | −24.3% | −19.8% | −13.8% |
| Net margin | −6.5% | −26.6% | −13.6% | −23.9% | −14.8% | −36.2% | 1.5% | −3.6% |
| Free-cash-flow margin | −23.5% | −42.1% | 11.6% | −37.9% | −11.3% | −23.4% | −3.6% | −0.0% |
| Current ratio | 2.29 | 1.71 | 1.54 | 3.28 | 3.13 | 3.31 | 3.30 | 2.61 |
| R&D as % of revenue | 14.8% | 14.0% | 13.2% | 13.5% | 13.7% | 13.9% | 13.8% | 11.2% |
| SG&A as % of revenue | 55.5% | 60.5% | 57.4% | 56.2% | 56.8% | 61.1% | 59.0% | 56.3% |
Financial health
- Short-term assets cover short-term liabilities $1.1bn of assets due within a year against $436m of liabilities due within a year.
- Short-term assets cover long-term liabilities $1.1bn short-term assets against $1.5bn of longer-dated liabilities.
- More cash than debt Cash or debt not separately reported. Not assessable.
- Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
- Operating profit covers interest at least five times over Operating income of −$279m against $47m of interest.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.
Compare with peers
- Waystar Holding Corp. statistics
- Omnicell, Inc. statistics
- Teladoc Health, Inc. statistics
- Goodrx Holdings, Inc. statistics
- Veeva Systems Inc statistics
Head to head: TEM vs WAYOMCL vs TEMTDOC vs TEMTEM vs VEEV
More: Health Care Technology stocks compared, Health Care sector, rankings of US companies